Clinical Trial Update: Letrozole and Celecoxib in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of letrozole plus celecoxib for postmenopausal women with locally advanced or metastatic breast cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CELEBREX (Celecoxib)
• FEMARA (letrozole)

Snippet

Sponsor: University of Medicine and Dentistry of New Jersey | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED